In the fixed-effects model, ABT showed a trend toward increased risk of disease progression (HR = 1.085; 95% CI: 0.995–1.176).
← all excerpts
A Silent Saboteur of Immunotherapy: Antibiotic Use and Its Impact on Immune Checkpoint Inhibitors Efficacy, a Systematic Review and Meta-Analysis of Recent Studies.
1
—
—